CSPC Signs Exclusive Licensing Deal with Madrigal for GLP-1 Agonist SYH2086
China-based CSPC Pharmaceutical Group Limited (HKG: 1093) announced today that it has entered into an...
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals’ Rezdiffra Earns FDA Accelerated Approval for NASH in Adults
The US Food and Drug Administration (FDA) has granted an accelerated approval to Madrigal Pharmaceuticals’...